Executive Summary

Oct 2019
PROSPECTS
Consumers are comfortable inquiring about and purchasing most dermatologicals but still feel embarrassment and stigma about some types

Dermatologicals continued to achieve healthy sales growth in the Philippines in 2019. Air pollution and hotter weather in the country contribute to the incidence of some skin conditions that consumers often choose to address with OTC treatments.

High birth rate promises opportunity for paediatric dermatologicals

The Philippines has become an attractive market for players to invest in due to its high birth rate compared to other countries within the ASEAN region. Among all the areas to invest in, the country offers an interesting opportunity for players specialising in dermatologicals, as this field has historically seen products for children being mainly limited to nappy (diaper) rash treatments.

Greater consumer knowledge of eczema supports sales of antipruritics

Demand for antipruritics continues to rise due to consumers becoming more aware of eczema. Social media, global influence, health advocates and brand campaigns have led to better consumer knowledge of this skin condition.

COMPETITIVE LANDSCAPE
Great changes seen in company shares due to GSK and Pfizer’s joint venture

On 1 August 2019, GlaxoSmithKline Plc (GSK) and Pfizer Inc completed the formation of their joint venture, combining their consumer healthcare businesses. This has created, under the GSK name, a global leading player in OTC products which holds first or second place in key geographies, including the US and China.

Filipinos’ image consciousness helps Novuhair retain its dominance of hair loss treatments

Local brand Novuhair from Nutramedica Inc was second in dermatologicals in 2019 but continued to dominate value sales of hair loss treatments. Novuhair is a popular and strong brand name which benefits from dynamic marketing activity and a wide distribution network.

Bayer sees a strong performance due to marketing Elica as suitable for children

In 2019, Bayer Philippines Inc continued to see strong growth in value sales and increased its value share due to the strong performance of its Elica brand in antipruritics. The company has invested significantly in marketing Elica as being suitable for children, recognising the great opportunity for growth due to the high birth rate in the Philippines.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in the Philippines

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Philippines with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Philippines, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Philippines market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Philippines?
  • What are the major brands in Philippines?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in the Philippines - Category analysis

HEADLINES

PROSPECTS

Consumers are comfortable inquiring about and purchasing most dermatologicals but still feel embarrassment and stigma about some types
High birth rate promises opportunity for paediatric dermatologicals
Greater consumer knowledge of eczema supports sales of antipruritics

COMPETITIVE LANDSCAPE

Great changes seen in company shares due to GSK and Pfizer’s joint venture
Filipinos’ image consciousness helps Novuhair retain its dominance of hair loss treatments
Bayer sees a strong performance due to marketing Elica as suitable for children

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2014-2019
Table 2 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 4 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2016-2019
Table 6 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Consumer Health in the Philippines - Industry Overview

EXECUTIVE SUMMARY

Steady growth continues in consumer health as the gap narrows between prevention and treatment
Air pollution and population growth contribute significantly to the growth of consumer health in 2019
Players use television advertising to increase brand awareness
Internet retailing makes gradual headway into consumer health
Stable growth is expected for consumer health in the forecast period as a balance is struck between consumers’ self-care and their price sensitivity

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 9 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2014-2019
Table 11 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 12 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 13 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources